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Abstract
Colonocytes possess a specific carrier-mediated uptake process for the microbiota-gener-
ated thiamin (vitamin B1) pyrophosphate (TPP) that involves the TPP transporter (TPPT;
product of the SLC44A4 gene). Little is known about the effect of exogenous factors (includ-
ing enteric pathogens) on the colonic TPP uptake process. Our aim in this study was to
investigate the effect of Enterohemorrhagic Escherichia coli (EHEC) infection on colonic
uptake of TPP. We used human-derived colonic epithelial NCM460 cells and mice in our
investigation. The results showed that infecting NCM460 cells with live EHEC (but not with
heat-killed EHEC, EHEC culture supernatant, or with non-pathogenic E. Coli) to lead to a
significant inhibition in carrier-mediated TPP uptake, as well as in level of expression of the
TPPT protein and mRNA. Similarly, infecting mice with EHEC led to a significant inhibition in
colonic TPP uptake and in level of expression of TPPT protein and mRNA. The inhibitory
effect of EHEC on TPP uptake by NCM460 was found to be associated with reduction in the
rate of transcription of the SLC44A4 gene as indicated by the significant reduction in the
activity of the SLC44A4 promoter transfected into EHEC infected cells. The latter was also
associated with a marked reduction in the level of expression of the transcription factors
CREB-1 and ELF3, which are known to drive the activity of the SLC44A4 promoter. Finally,
blocking the ERK1/2 and NF-kB signaling pathways in NCM460 cells significantly reversed
the level of EHEC inhibition in TPP uptake and TPPT expression. Collectively, these find-
ings show, for the first time, that EHEC infection significantly inhibit colonic uptake of TPP,
and that this effect appears to be exerted at the level of SLC44A4 transcription and involves
the ERK1/2 and NF-kB signaling pathways.
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Introduction
Thiamin pyrophosphate (TPP; also called thiamin di-phosphate), is a biologically active form
of vitamin B1 that acts as a cofactor for multiple enzymes (pyruvate dehydrogenase, α-ketoglu-
tarate dehydrogenase, branched-chain α-ketoacid dehydrogenase, transketolase) that are
involved in critical metabolic reactions (e. g., energy metabolism, reduction of cellular oxida-
tive stress) [1, 2, 3]. The vitamin also plays a role in maintaining normal mitochondrial func-
tion and structure [4], and in cellular pro-inflammatory responses [5, 6]. Deficiency of
thiamin in humans leads to serious clinical abnormalities (that include cardiovascular and
neurological disorders), and occurs in chronic alcoholism and diabetes mellitus among other
conditions [7, 8, 9].
Human/other mammals lack the ability to synthesize thiamin endogenously; therefore, they
must obtain the micronutrient from exogenous sources via intestinal absorption. The intestine
encounters two sources of thiamin: dietary and bacterial sources (the latter is in reference to
the vitamin that is generated by the gut microbiota). With regards to the dietary source, the
vitamin exists mainly in the phosphorylated form; this form is hydrolyzed to free thiamin
prior to absorption by the action of the abundant small intestinal phosphatases [10, 11, 12].
The liberated free thiamin is then absorbed via a specific carrier-mediated process that
involves both the SLC19A2 (THTR-1) and SLC19A3 (THTR-2) transport systems [10–17]. As
to the microbiota-generated vitamin B1, this source provides thiamin in both the free and the
phosphorylated (i. e., TPP) forms [12, 18]. Studies from our laboratory have shown that the
human/mammalian colonocytes are capable of absorbing both of these forms of the vitamin
and that this occurs via distinct and specific carrier-mediated mechanisms [19–21]. Large
intestinal absorption of free thiamin involves the SLC19A2 and SLC19A3 uptake systems [12,
19, 22], while that of TPP involves the recently identified TPPT system (product of the
SLC44A4 gene) [20, 21]. Other studies from our laboratory have shown that expression of the
SLC44A4 system in the gastrointestinal tract is restricted to the large intestine [21], and that
this site-specific expression is determined by epigenetic mechanisms [23]. In addition, we have
characterized different regulatory aspects of the TPPT system, identified a role for the cis-regu-
latory elements CREB-1 and ETS/ELF3 in basal activity of the SLC44A4 promoter [24], and
showed that the colonic TPP uptake process is adaptively-regulated by the prevailing extracel-
lular substrate level [20, 25]. Very little, however, is known about the effect of external factors
(including that of enteric pathogens) on the colonic TPP uptake process. In this study, we
examined the effect of one such factor, i. e., infection with Enterohemorrhagic E. coli (EHEC),
on colonic uptake of TPP. EHEC causes foodborne diarrhea in humans, and it mainly colo-
nizes the colon and exert its effect via toxin -dependent and toxin-independent mechanisms
[26, 27, 28]. We used the human-derived colonic epithelial NCM460 cells and mice for in vitro
and in vivo models of infection, respectively. Our results showed that EHEC infection causes a
significant inhibition in colonic TPP uptake and that this inhibition is exerted at the level of
transcription of the SLC44A4 gene and involves the ERK1/2 and NF-kB signaling pathways.
Materials and methods
Materials
NCM460 cells were from INCELL (San Antonio, TX), and [3H]-TPP (specific activity 1.3 Ci/
mmol; radiochemical purity 97%) was from Moravek Biochemicals (Brea, CA); qPCR primers
were from Sigma Genosys (Woodlands, TX); Other chemicals/reagents were from commercial
vendors and were of analytical/molecular biology grade. Human and mouse specific anti-
SLC44A4 polyclonal antibodies were generated for us by Alpha Diagnostics International (San
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Antonio, TX) and by Thermofisher (Rockford, IL), respectively. Human anti-ELF3 (AV31639)
antibody was from Sigma-Aldrich (Saint Louis, MO); anti-CREB-1 (#9197), anti-ERK1/2
(#9102S), anti-Phospho ERK1/2 (#9101S) and anti-Phospho NF-κB (#3033S) were from Cell
Signaling Technology (Danvers, MA); anti-NF-κB (ab16502) antibody from Abcam (Cam-
bridge, MA); anti-β-actin (sc-47778) and anti-Lamin B (sc-6216) antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). The secondary antibodies, anti-rabbit IRDye-800 and
anti-mouse IRDye-680, were purchased from LI-COR Bioscience (Lincoln, NE).
Cell culture
The human-derived colonic non-transformed NCM460 epithelial cells were routinely main-
tained in Ham’s F-12 culture medium supplemented with 20% (vol/vol) FBS and antibiotics at
37˚ C in a 5% CO2 environment. Confluent NCM460 cell monolayers were used in the physio-
logical and molecular investigations.
Bacterial culture and infection of NCM460 cells
Wild-type EHEC (EDL933), as well as the EHEC mutants EHEC Δtir, EHEC ΔespF and EHEC
ΔescN (all were kindly provided to us by Dr. G Hecht, of Loyola University Chicago, IL), and
the non-pathogenic E. coli HS4 strain were used in this study. Overnight bacterial cultures
were diluted to 1:50 in Luria-Bertani (LB) broth (EHEC ΔespF and EHEC ΔescN were grown
in presence of 50 μg/ml kanamycin) and allowed to grow for 3 h to reach the exponential
phase. Bacteria were resuspended in serum free media at the specified multiplicity of infection
(MOI). Confluent NCM460 cells maintained in serum free media were infected with 200 MOI
of wild-type EHEC and their mutants for 5 h [29, 30], then treated with gentamycin (50 μg/ml)
for 60 min (to remove adherent EHEC), followed by utilization in the different studies. To
study the effect of heat-killed (boiled) EHEC (200 MOI) on NCM460 cells, the bacteria was
boiled for 30 min at 100˚ C.
Bacterial culture supernatants
To collect bacterial culture supernatant, the overnight grown EHEC culture was centrifuged
for 15 mins at 3000 rpm, followed by filtration (utilizing 0.22 μm sterile syringe filters) as
described previously [31, 32].
[3H]-TPP uptake studies in vitro and in vivo
Initial rate of carrier-mediated uptake (3 min at 37˚ C) of TPP [3H]-TPP (0.3 μCi/ml) [20, 21]
was assayed in EHEC infected NCM460 cells (in vitro) using Krebs-Ringer (KR) buffer con-
taining (in mM): 123 NaCl, 4.93 KCl, 1.23 MgSO4, 0.85 CaCl2, 5 glucose, 5 glutamine, 10
HEPES, and 10 MES (pH 7.4). Uptake reaction was terminated by the addition of ice-cold KR
buffer followed by cell lysis (with 1 ml of 1 N NaOH), neutralization with 10 N HCl and radio-
active counting in a liquid scintillation counter. Protein content of cell digests was measured
using the Dc protein assay kit (Bio-Rad, Hercules, CA). For in vivo TPP uptake, eight-weeks-
old C57BL/6J mice (~ 25 g) were given water containing streptomycin (5 g/L) for 24 h to elimi-
nate the commensal microflora. The water was then replaced with regular water for another 24
h before bacterial infection. Mice were gavaged with 2x108 CFU/mice (in 200 μl) [33] using
20-gauge gavage needle. Control (uninfected) mice were gavaged with same volume of PBS.
After 72 h of infection, mice were euthanized and the colon sheet (~ 1 cm) were incubated in
vitro in KR buffer containing [3H]-TPP in the presence or absence of unlabeled 1mM TPP for
10 minutes and then processed for radioactivity measurement. The animal protocol used in
EHEC inhibits colonic TPP uptake
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this study was approved by the Institutional Animal Care and Use Committee (IACUC), Uni-
versity of California, Irvine, CA.
Quantitative real-time PCR analysis (RT-qPCR)
Total RNA isolated from NCM460 cells, and mouse colon infected with EHEC, were reverse
transcribed (using iScript cDNA synthesis kit from Bio-Rad; Hercules, CA). Human and
mouse gene specific primers (Table 1) were used to amplify the appropriate genes and PCR
conditions were used as described previously [34]. Data was normalized to β-actin were quan-
tified using a relative relationship method supplied by the iCycler manufacturer (Bio-Rad).
Transfection and firefly luciferase assay
SLC44A4 wild-type (WT) promoter construct (3 μg/ml), along with 100 ng of Renilla lucifer-
ase-thymidine kinase (pRL-TK) plasmid (Promega, Madison, WI), were transiently trans-
fected in NCM460 cells using Lipofectamine 2000 reagent (Life Technologies) for 24 h. Cells
were subsequently infected with EHEC, then (5 h later) washed with gentamycin then lysed.
The Renilla-normalized firefly luciferase activity was determined using a dual-luciferase assay
system (Promega).
Isolation of protein and western blot analysis
EHEC infected and uninfected NCM460 cells and mouse colon tissues were lysed in radio
immunoprecipitation assay buffer (RIPA buffer; Sigma) containing complete protease inhibi-
tor cocktail (Roche, NJ). The soluble protein fraction was collected followed by centrifugation
(12,000 rpm, 20 min). Concentrations of proteins were determined using Dc protein assay kit
(Bio-Rad). To determine the level of TPP transporter and transcription factors protein expres-
sion, an equal amount of protein (40 μg) was loaded onto 4–12% Bis-Tris gradient minigels
(Invitrogen) and transferred in to Immobilon polyvinylidene difluoride membrane (Fisher
Scientific). Subsequently, the blots were probed with anti-TPPT (1:200), anti-CREB-1 (1:200),
anti-ELF3 (1: 200), anti-ERK1/2 (1:1000), anti-Phospho ERK1/2 (1:1000), anti-Phospho NF-
κB (1:1000), anti-NF-κB (1:1000), anti-β-actin (1:3000), and anti-Lamin B (1: 1000) antibodies.
The membranes were probed with anti-mTPPT antibody and anti-mTPPT antibody pre-
treated with antigenic peptide to show the specificity of the mTPPT antibody. Anti-rabbit
IRDye-800 and anti-mouse IRDye-680 (both at 1:30,000 dilutions) were used as the secondary
antibodies in this study. The specific immunoreactive bands were detected using the Odyssey
infrared imaging system (LI-COR Bioscience, Lincoln, NE), and their densities were measured
using the LI-COR software.
Table 1. Primers used for real-time PCR analysis.
Gene Name Forward and Reverse Primers (50– 30)
hSLC44A4 TGCTGATGCTCATCTTCCTGCG; GGACAAAGGTGACCAGTGGGTA
hCREB-1 TTAACCATGACCAATGCAGCA; TGGTATGTTTGTACGTCTCCAGA
hELF3 TCTTCCCCAGCGATGGTTTTC; TCCCGGATGAACTCCCACA
h-β-actin CATCCTGCGTCTGGACCT; TAATGTCACGCACGATTTCC
mSlc44a4 TGCCTACCAGAGTGTGAAGGAG; TGGCTTCCTTCAGCAGAGCGAT
m-β-actin ATCCTCTTCCTCCCTGGA; TTCATGGATGCCACAGGA
https://doi.org/10.1371/journal.pone.0224234.t001
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Treatment of NCM460 cells with inhibitors
The ERK1/2 pathway specific inhibitor PD98059 (Peprotech, Rocky Hill, NJ) and the NF-kB
pathway specific inhibitor Celastrol (Invivogen, San Diego, CA) were stored at -20˚ C. Prior to
EHEC infection, the NCM460 cells were incubated with either PD98059 (50 μM) or Celastrol
(100 nM) for 1h. The inhibitors were kept during the 5 h of infection.
Statistical analysis
Uptake data presented in this study represent mean ± SE of 3 independent experiments (done
on different occasions) and are expressed as percentage relative to simultaneously performed
controls. The RT-qPCR, western blotting, and firefly luciferase assays were determined from
three independent samples preparations. For statistical analysis, we used the Student’s t-test
and P< 0.05 was considered to be statistically significant.
Results
Effect of EHEC on physiological/molecular parameters of the colonic TPP
uptake process
In vitro studies using human-derived colonic epithelial NCM460 cells. We examined
the effect of EHEC infection (using different multiplicity of infection, MOI), as well as that of
the non-pathogenic E. coli HS4 (200 MOI), of colonic epithelial NCM460 cells on TPP uptake.
For this, cells were exposed to EHEC for 5 h [29, 30], followed by evaluation of initial rate of
carrier-mediated [3H]-TPP (0.23 μM) uptake [20]. The result showed a significant (P < 0.05
for 100 MOI, and P< 0.01 for 200 MOI) inhibition in TPP uptake by NCM460 cells infected
with EHEC (but not with non-pathogenic E. coli HS4) compared with simultaneously pro-
cessed uninfected controls (Fig 1A). A 200 MOI was used for all subsequent experiments. In
another study, we investigated the effect of treating NCM460 cells with boiled EHEC (heat-
killed bacteria) on TPP uptake with the results showing lack of effect on the vitamin uptake
(Fig 1B). To assess whether the inhibition in TPP uptake caused by live EHEC is mediated via
a secreted factor (toxin), we exposed the NCM460 cells to supernatant of culture EHEC (see
“Methods”), then examined [3H]-TPP uptake. The result showed lack of inhibition of such a
treatment on TPP uptake (Fig 1B).
EHEC causes attaching and effacing lesion via type III secretion system (T3SS), the molecu-
lar syringe that injects effector proteins into host cells. Thus, we examined functional involve-
ment of EHEC effector proteins in the EHEC-induced inhibition in TPP uptake by NCM460
cells. For this, we used 200 MOI of EHEC Δtir (the translocated Intimin receptor facilitates the
intestinal colonization), EHEC ΔespF (a multifunctional protein mainly involved in EHEC
colonization) and EHEC ΔescN (putative ATPase component involved in the formation of
T3SS and intestinal colonization) [29, 35] to infect NCM460 cells. Results showed a significant
inhibition in TPP uptake by NCM460 cells infected with wild-type EHEC and their mutants,
suggesting that these effector proteins are not required for the EHEC induced inhibition TPP
uptake inhibition (Fig 1C).
In another study, we examined the effect of infecting NCM460 cells with EHEC (200 MOI;
5 h exposure) on level of TPPT protein expression. This was done by means of western blotting
using specific polyclonal antibodies against the TPP transporter [25]. The result showed a sig-
nificant (P< 0.01) reduction in the level of expression of the TPPT protein in cells infected
with EHEC compared to uninfected controls (Fig 1D). We also examined (by mean RT-
qPCR) the effect of infecting the NCM460 cells with EHEC on level of SLC44A4 mRNA
EHEC inhibits colonic TPP uptake
PLOS ONE | https://doi.org/10.1371/journal.pone.0224234 October 22, 2019 5 / 14
expression. The result showed a significant (P < 0.01) reduction in the level of expression of
SLC44A4 mRNA in cells infected with EHEC compared to uninfected cells (Fig 1E).
In vivo studies in mice. In these studies, we investigated the effect of EHEC infection of
mice in vivo on physiological/molecular parameters of the colonic TPP uptake process. For
this, we gavaged C57BL/6J mice with EHEC (2x108 CFU/mice; [33]), then examined TPP
uptake 72 h following infection. The result showed a significant (P < 0.01) inhibition in
colonic carrier-mediated TPP uptake (Fig 2A). We also examined (by western blot analysis)
the level of TPPT protein expression in colonic cells of the infected mice and observed a signif-
icant (P < 0.01) reduction in mice infected with EHEC compared to uninfected controls (Fig
2B). Similarly, level of Slc44a4 mRNA expression (determined by RT-qPCR) was found to be
significantly (P < 0.05) reduced in EHEC infected mice compared to uninfected control (Fig
2C).
Fig 1. Effect of EHEC infection of human colonic epithelial NCM460 cells in vitro on carrier-mediated TPP uptake and on level of expression of TPP transporter
(TPPT). [A] Carrier-mediated [3H]-TPP uptake was examined in NCM460 cells infected with EHEC at 100 and 200 MOI for 5 h. [B] Carrier-mediated TPP uptake was
examined in NCM460 cells exposed to boiled (heat-killed) EHEC or bacterial culture supernatant. [C] Effect of infection with EHEC mutants (Δtir-EHEC,
ΔespF-EHEC and ΔescN-EHEC) on [3H]-TPP uptake by NCM460 cells. [D] Levels of TPPT protein expression was examined in NCM460 cells infected with EHEC at
200 MOI for 5 h (by western blotting). Data were normalized with β-actin. [E] Levels of SLC44A4 mRNA expression was examined in NCM460 cells infected with
EHEC at 200 MOI for 5h (by RT-qPCR). Data are mean ± SE of 3–4 sets of independent experiments. ��P< 0.01; � P< 0.05; NS-not significant.
https://doi.org/10.1371/journal.pone.0224234.g001
EHEC inhibits colonic TPP uptake
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Involvement of transcriptional mechanism in the effect of EHEC on
colonic TPP uptake process
A change in level of expression of a given mRNA could be induced via multiple mechanisms
including changes in the rate of transcription of the involved gene. To determine possible
involvement of the latter mechanism in the observed effect of EHEC infection on expression
of the colonic SLC44A4 mRNA, we examined the effect of EHEC infecting of NCM460 cells
expressing the full-length (and minimal-length) SLC44A4 promoters (fused to the luciferase
reporter) on activity of these promoters. The results showed that a significant inhibition in the
activity of the SLC44A4 full-length (P< 0.05) as well as the minimal (P< 0.01) promoters con-
structs in cells infected with EHEC compared to uninfected controls (Fig 3A & 3B). These
results demonstrated that the effect of EHEC infection on SLC44A4 expression is, at least in
part, mediated at the level of transcription of the SLC44A4 gene.
Fig 2. Effect of EHEC infection of mice in vivo on colonic carrier-mediated TPP uptake and on level of expression of TPPT. [A] Carrier-mediated
[3H]-TPP uptake was examined in colonic sheet of C57BL/6J male mice (8–10 week-old) infected with EHEC for 72 h. [B] Levels of TPPT protein
expression was examined in EHEC infected mouse colonic tissue. The membranes were incubated with custom made anti-TPPT antibodies [i] and anti-
TPPT antibodies pretreated with antigenic peptide [ii]. The antigenic peptide was used to show the specificity of the TPPT. [C] Levels of Slc44a4 mRNA
expression was examined in EHEC infected colonic tissue. Data are mean ± SE of 3–4 pairs of mice. ��P< 0.01; �P< 0.05.
https://doi.org/10.1371/journal.pone.0224234.g002
EHEC inhibits colonic TPP uptake
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Previous findings from our laboratory have shown that the nuclear factors CREB-1 and
ELF3 play important roles in driving basal promoter activity of the SLC44A4 gene [24]. Thus,
we also examined whether EHEC infection of NCM460 cells affects the expression of the
CREB-1 and ELF3 transcription factors. The results showed that infecting NCM460 cells with
EHEC leads to a significant (P < 0.01 for both) suppression in level of CREB-1 and ELF3 pro-
tein (Fig 4A & 4B), and mRNA (Fig 4C & 4D) expression.
Role of ERK1/2 and NF-κB signaling pathways in mediating the inhibitory
effect of EHEC on TPP uptake
It has been shown previously that EHEC infection of intestinal epithelial cells leads to a signifi-
cant activation of the ERK 1/2 and NF-κB intracellular signaling pathways [36–38]. Thus, we
first examined whether EHEC infection can activate ERK 1/2 and NF-κB signaling pathways
in colonic NCM460 cells. The results showed that the phosphorylation of ERK1/2 and NF-κB
was increased in EHEC-infected cells compared to uninfected control as well as to cells treated
with ERK1/2 and NF-κB pathway inhibitors prior to EHEC infection (Fig 5A). These results
indicate that EHEC infection in NCM460 cells activates these two pathways. Next, to deter-
mine whether these signaling pathways are involved in mediating the inhibition caused by
EHEC in colonic TPP uptake and in level of expression of the TPPT, we used specific pharma-
cological inhibitors to block these pathways and examined the effect of such blocking on the
inhibitory effect of EHEC on these parameters. We used the ERK 1/2 specific inhibitor
PD98059 and the NF-κB specific inhibitor celastrol in our investigations [36–38]. The result
showed that treatment of cells with PD98059 and celastrol to lead to significant (P< 0.01)
abrogation in the inhibitory effect of EHEC on TPP uptake (Fig 5B) as well as on the level of
expression of TPPT protein (Fig 5C & 5D). These findings suggest that ERK 1/2 and NF-kB
Fig 3. Effect of EHEC infection of NCM460 cells on activity of the SLC44A4 promoter. The relative promoter activity of human
SLC44A4 full-length [A] and minimal promoter [B] constructs in pGL3 basic was examined in NCM460 cells infected with EHEC (200
MOI for 5 h) by luciferase assay. The relative values of promoter activity are expressed as fold change over pGL3 basic vector and data are
presented as mean ± SE of 4 sets of independent experiments. ��P< 0.01; �P< 0.05.
https://doi.org/10.1371/journal.pone.0224234.g003
EHEC inhibits colonic TPP uptake
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signaling pathways are involved in mediating the effect of EHEC on the physiology and molec-
ular biology of colonic TPP uptake process.
Discussion
As mentioned earlier, studies from our laboratory have recently shown that the SLC44A4
transport system is involved in the uptake of the microbiota-generated TPP and that expres-
sion of this transporter along the GI tract is restricted to the large intestine [21, 23]. We also
shown that this uptake system is specific for TPP and does not transport the free form of vita-
min B1, i. e., free thiamin. In addition, we have characterized different cell biology and regula-
tory aspects of this colonic TPPT system [20, 24, 25]. Currently, there is little known about the
Fig 4. Effect of EHEC infection of NCM460 cells on level of expression of CREB-1 and ELF3 proteins and mRNAs. Levels of CREB-1 [A] and ELF3 [B] proteins
expression were determined in NCM460 cells infected with EHEC (200 MOI for 5 h) by western blotting. Normalization of both the proteins expression was done
relative to Lamin B. Levels of CREB-1 [C] and ELF3 [D] mRNA expression was determined in NCM460 cells infected with EHEC by RT-qPCR. Normalization of
both the mRNAs expression was done by β-actin. Data are mean ± SE of 3 sets of independent experiments. ��P< 0.01.
https://doi.org/10.1371/journal.pone.0224234.g004
EHEC inhibits colonic TPP uptake
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effect of external/ environmental factors on the function of this newly identified uptake system.
In this study, we examined the effect of infection with the enteric pathogen EHEC on physiol-
ogy/molecular biology of the colonic TPP uptake process. EHEC is a major enteric pathogen
that causes foodborne diarrheal disease in the US; it affects approximately 75,000 individuals
annually [39, 40]. Severe infection with this pathogen causes intestinal inflammation, hemor-
rhagic colitis, which could be followed by life-threatening hemolytic uremic syndrome [36,
37]. EHEC infection mainly impacts the colon and its effect is mediated via toxin-dependent
and toxin-independent mechanisms [26, 27, 28]. Although EHEC has been shown to affect the
physiology of ion transport in the colon [27, 40–43], its effect on uptake of micro-nutrients
like water-soluble vitamins (including TPP) has not been examined. In this study, we
employed as models: a well-established human-derived colonic epithelial NCM460 cells (for in
Fig 5. Role of ERK 1/2 and NF-κB signaling pathways in mediating the effect of EHEC infection of NCM460 cells on TPP uptake and on level of expression of
TPPT. [A] Activation of ERK1/2 (i) and NF-κB (ii) in EHEC infected NCM460 cells. Cells were treated with EHEC and pretreated with 50 μM PD98059 (an ERK1/2
inhibitor) and 100 nM celastrol (an inhibitor of NF-kB). [B] Carrier-mediated [3H]-TPP uptake was examined in NCM460 cells that were pre-treated with PD98059 and
celastrol for 1 h prior to EHEC (200 MOI for 5 h) infection. [C and D] Levels of TPPT protein expression in NCM460 cells that were pre-treated with PD98059 and
celastrol prior to EHEC infection, respectively (western blotting). Data are mean ± SE of 4–6 different sets of independent experiments. ��P< 0.01; �P< 0.05; NS-not
significant; PD-PD98059 (inhibitor of ERK1/2) and celastrol (inhibitor of NF-κB).
https://doi.org/10.1371/journal.pone.0224234.g005
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vitro infection) and mice for (in vivo infection) to examine the effect of EHEC on colonic
uptake of TPP. The results demonstrated that infection of NCM460 cells with live EHEC (but
not heat-killed/boiled EHEC or with non-pathogenic E. coli) causes a marked inhibition in
TPP uptake; no such inhibition in the substrate uptake was observed in cells treated with bac-
terial culture supernatant suggesting that the effect is not mediated via a secreted factor(s)
(toxin) but rather it requires a direct contact of the bacterial with the colonic epithelial cells.
Non-toxin mediated effect of EHEC infection on intestinal physiology has also been seen by
others [33]. In addition, EHEC mutants with mutations in specific components of the T3SS
system (Δtir-EHEC, ΔespF-EHEC and ΔescN-EHEC) also showed significant inhibition in
TPP uptake, suggesting that these effector proteins are not involved in the EHEC mediated
inhibition in TPP uptake. Similarly, in vivo infection of mice with EHEC led to a significant
inhibition in colonic uptake of TPP. The inhibitory effect of EHEC on TPP uptake by human
and mouse colonocytes was associated with a marked suppression in level of expression of
TPPT protein and mRNA; the latter suggests that the effect is, at least in part, mediated at the
level of transcription of the SLC44A4 gene. This indeed appeared to be the case as activity of
the full-length (as well as the minimal) SLC44A4 promoter (transfected into NCM460 cells)
were significantly reduced following infection with EHEC. Since the CREB-1 and ELF3
nuclear factors participate in driving promoter activity of the SLC44A4 gene [24], we also
examined whether EHEC infection of NCM460 cells affects expression of these factors. The
results indeed showed that EHEC infection leads to a significant inhibition in the expression
of both of these nuclear factors raising the possibility that they may be involved in mediating
the inhibitory effect of EHEC on SLC44A4 promoter activity.
Previous investigations have reported that the intracellular ERK 1/2 and NF-κB signaling
pathways mediate the effects of EHEC on intestinal epithelial cells physiology [36–38]. Thus, we
investigated whether these signaling pathways are also involved in mediating the inhibitory effect
of EHEC on the physiology/molecular biology of the colonic TPP uptake process. For this, we
used specific pharmacological inhibitors to suppress these pathways [36–38] and examined the
effect of such treatment on the inhibitory effect of EHEC on TPP uptake and on expression of
the TPPT protein in NCM460 cells. The results showed that inhibiting these signaling pathways
to significantly reverse the inhibitory effect of EHEC on colonic TPP uptake and on level of
TPPT protein expression. These findings suggest a role for these signaling pathways in mediating
the inhibitory effect of EHEC on colonic TPP uptake and on level of expression of the TPPT.
Conclusion
Results of these investigations show, for the first time, that EHEC infection inhibits colonic
TPP uptake as well as level of expression of the involved transporter (i. e., TPPT), and that this
inhibition is mediated, at least in part, at the level of SLC44A4 transcription and may involve
the ERK 1/2 and NF-κB signaling pathways.
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